advocacy

Politics By Nicholas Florko

Amid Covid-19, tiny biotech companies are hiring lobbyists for the first time

First Opinion By Gunnar Esiason and Emma D'Agostino

Health care conferences should embrace patients as collaborators

Politics By Lev Facher

AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018

Exclusive By Nicholas Florko

In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies

Politics By Nicholas Florko

PhRMA’s top communicator, a fierce defender of the industry, leaves for ExxonMobil

Exclusive By Nicholas Florko and Matthew Herper

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?

Politics By Lev Facher

General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic

Politics By Nicholas Florko

Congress’s coronavirus stimulus package contains plenty of unrelated wins for the health industry

First Opinion By Sarah Temkin

When surgery becomes ‘women’s work’: the devaluation of gynecologic specialties

First Opinion By Keita Mori

The U.S. needs a nationwide registry for traumatic brain injury

Health By Nicholas Florko

PhRMA closes its D.C. headquarters after visitor tests positive for coronavirus

Politics By Nicholas Florko

The coronavirus could help pharma reset its reputation in Washington

Politics By Lev Facher

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

First Opinion By Mark McClellan and Ellen V. Sigal

The FDA in the 2020s: move forward, don’t stand still

First Opinion By Stephen Lamb

Why we need mandatory labeling of GMO products

First Opinion By Robert Klitzman

Paying gestational carriers should be legal in all states

First Opinion By Marian W. Wentworth

To maximize progress in global health, invest more in community health workers

Politics By Nicholas Florko

Employers shoulder plenty of drug costs, but haven’t lobbied much to lower them — until now

First Opinion By Shannon Brownlee and Judith Garber

‘Small’ tactics to counter Big Pharma’s influence on medication overload

Health By Lev Facher

It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats

Politics By Nicholas Florko

Want to know how contentious drug pricing is in Washington? Check the receipts

Health By Nicholas Florko

Congress calls Juul, four other vape companies to testify about youth vaping

Politics By Lev Facher

Democrats zero in on high drug prices in Iowa debate

First Opinion By Matthew Cooper

Medicare policy on antirejection drugs imperils kidney transplants

First Opinion By 215 Biopharma CEOs and Industry Leaders

A new biotechnology and pharmaceutical industry commitment to patients and the public